Summit Therapeutics Inc (SMMT)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -60.525 | -53.029 | -82.088 | -20.264 | -141.833 |
| Return on Equity (%) | -73.867 | -66.572 | -108.89 | -75.053 | -601.85 |
| Return on Invested Capital (%) | -67.3 | -64.265 | -104.78 | -17.821 | -153.633 |
| Operating Margin (%) | -3876.178 | -6122.674 | -4882.311 | -10550.496 | N/A |
| Net Profit Margin (%) | -3920.188 | -6127.558 | -4897.844 | -11174.752 | N/A |
| Book Value Per Share | 0.949 | 0.798 | 0.723 | 0.591 | 0.108 |
| Earnings Per Share | -0.434 | -0.638 | -0.904 | -0.373 | -0.877 |
| Cash Per Share | 0.95 | 0.804 | 0.732 | 1.651 | 0.102 |
| Working Capital Per Share | 0.98 | 0.821 | 0.731 | 2.927 | 0.242 |
| Operating Profit Per Share | 0.352 | 0.244 | 0.232 | 0.072 | 0.001 |
| EBIT Per Share | -0.433 | -0.641 | -0.904 | -0.373 | -0.877 |
| EBITDA Per Share | -0.433 | -0.641 | -0.904 | -0.373 | -0.877 |
| Free Cash Flow Per Share | -0.448 | -0.652 | -0.914 | -0.376 | -0.878 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 67.18M | 82.58M | 98.04M | 211.09M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Shares Outstanding | 211.09M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 15.86B |
| Price to Earnings Ratio | -23.97 |
| Price to Sales Ratio | 14.28k |
| Price to Cash Ratio | 206.3 |
| Price to Book Ratio | 189.74 |
| Dividend Yield | - |
| Shares Outstanding | 737.45M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
